These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 8419003)
1. Indobufen in the prevention of thromboembolic complications in patients with heart disease. A randomized, placebo-controlled, double-blind study. Fornaro G; Rossi P; Mantica PG; Caccia ME; Aralda D; Lavezzari M; Pamparana F; Milanesi G Circulation; 1993 Jan; 87(1):162-4. PubMed ID: 8419003 [TBL] [Abstract][Full Text] [Related]
2. Indobufen: an updated review of its use in the management of atherothrombosis. Bhana N; McClellan KJ Drugs Aging; 2001; 18(5):369-88. PubMed ID: 11392445 [TBL] [Abstract][Full Text] [Related]
3. A randomized trial comparing ticlopidine hydrochloride with indobufen for the prevention of stroke in high-risk patients (TISS Study). Ticlopidine Indobufen Stroke Study. Bergamasco B; Benna P; Carolei A; Rasura M; Rudelli G; Fieschi C Funct Neurol; 1997; 12(1):33-43. PubMed ID: 9127122 [TBL] [Abstract][Full Text] [Related]
4. Indobufen versus warfarin in the secondary prevention of major vascular events in nonrheumatic atrial fibrillation. SIFA (Studio Italiano Fibrillazione Atriale) Investigators. Morocutti C; Amabile G; Fattapposta F; Nicolosi A; Matteoli S; Trappolini M; Cataldo G; Milanesi G; Lavezzari M; Pamparana F; Coccheri S Stroke; 1997 May; 28(5):1015-21. PubMed ID: 9158644 [TBL] [Abstract][Full Text] [Related]
5. Double-blind, controlled, multicenter study of indobufen versus placebo in patients with intermittent claudication. Tönnesen KH; Albuquerque P; Baitsch G; Gomez Alonso A; Ibanez F; Kester RC; Leveson S; Poredos P Int Angiol; 1993 Dec; 12(4):371-7. PubMed ID: 8207316 [TBL] [Abstract][Full Text] [Related]
6. Effects of antiplatelet therapy with indobufen or aspirin-dipyridamole on graft patency one year after coronary artery bypass grafting. Rajah SM; Nair U; Rees M; Saunders N; Walker D; Williams G; Critchley A; Beton D; Campbell C; Lawson RA J Thorac Cardiovasc Surg; 1994 Apr; 107(4):1146-53. PubMed ID: 8159037 [TBL] [Abstract][Full Text] [Related]
7. Indobufen in secondary prevention of transient ischaemic attack. Multicentre Ischaemic Attack Study Group. Rogan J J Int Med Res; 1990; 18(3):240-4. PubMed ID: 2193837 [TBL] [Abstract][Full Text] [Related]
8. [Assessment of complications of major orthopedic surgery: comparison of indobufen, calcium heparin, and low molecular heparin]. Borghi B; Bassi A; Grazia M; Feoli MA; Pignotti E Minerva Anestesiol; 1996 Mar; 62(3):93-100. PubMed ID: 8767154 [TBL] [Abstract][Full Text] [Related]
9. [Italian Study on Atrial Fibrillation (SIFA): status report]. Amabile G; Matteoli S; Fattapposta F; Lavezzari M; Trappolini M; Heiman F; Morocutti C Cardiologia; 1993 Dec; 38(12 Suppl 1):327-32. PubMed ID: 8020032 [TBL] [Abstract][Full Text] [Related]
10. A double-blind placebo-controlled trial of indobufen in the prophylaxis of migraine. Carrieri PB; Orefice G; Sorge F Acta Neurol Scand; 1988 Jun; 77(6):433-6. PubMed ID: 3043994 [TBL] [Abstract][Full Text] [Related]
11. [Guidelines for antithrombotic therapy in atrial fibrillation: what the Italian Hemostasis and Thrombosis Society thinks]. Prisco D Haematologica; 2001 Sep; 86(9 Suppl):12-3. PubMed ID: 11759618 [No Abstract] [Full Text] [Related]
12. Indobufen versus placebo in the prevention of restenosis after carotid endarterectomy: a double-blind pilot study. Pratesi C; Pulli R; Milanesi G; Lavezzari M; Pamparana F; Bertini D J Int Med Res; 1991; 19(3):202-9. PubMed ID: 1936509 [TBL] [Abstract][Full Text] [Related]
13. The incidence of deep venous thrombosis in patients with an acute myocardial infarction treated with acenocoumarol or indobufen. Peters SH; Jonker JJ; de Boer AC; den Ottolander GJ Thromb Haemost; 1982 Oct; 48(2):222-5. PubMed ID: 7179201 [TBL] [Abstract][Full Text] [Related]
14. Indobufen. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in cerebral, peripheral and coronary vascular disease. Wiseman LR; Fitton A; Buckley MM Drugs; 1992 Sep; 44(3):445-64. PubMed ID: 1382938 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of spontaneous platelet aggregation and adhesion by indobufen (K 3920). A randomized, double-blind crossover study on platelet, coagulation and fibrinolysis function tests. Nenci GG; Berrettini M; Iadevaia V; Parise P; Ballatori E Pharmatherapeutica; 1982; 3(3):188-94. PubMed ID: 7134226 [TBL] [Abstract][Full Text] [Related]
16. Long-term evaluation of indobufen in peripheral vascular disease. Belcaro G; De Simone P Angiology; 1991 Jan; 42(1):8-14. PubMed ID: 1992862 [TBL] [Abstract][Full Text] [Related]
17. The effect of indobufen on the thrombogenic potential of a Dacron prosthesis in an artificial circulation. Sheehan SJ; Monson JR; Salter MC; Rajah DS; Rajah SM; Kester RC Eur J Vasc Surg; 1988 Aug; 2(4):223-7. PubMed ID: 2975227 [TBL] [Abstract][Full Text] [Related]
18. [Indobufen and calcium heparin for the prevention of thromboembolism in hip prosthesis surgery in patients who have undergone hemodilution]. Borghi B; Bugamelli S; deSimone N; Montebugnoli M; Ferrari S Minerva Anestesiol; 1990 Oct; 56(10):1117-20. PubMed ID: 2290518 [No Abstract] [Full Text] [Related]
19. [Heparan sulphate in association with indobufen in the treatment of chronic peripheral obliterative arteriopathy of the lower extremities. Controlled clinical trial]. Rossini A; Tascino C; Costa F Minerva Cardioangiol; 1998 Nov; 46(11):457-69. PubMed ID: 10207294 [TBL] [Abstract][Full Text] [Related]
20. A prostacyclin-sparing effect of indobufen vs. aspirin. De Caterina R; Giannessi D; Bernini W; Lazzerini G; Lavezzari M; Stragliotto E; Biagi G; Coccheri S Thromb Haemost; 1996 Mar; 75(3):510-4. PubMed ID: 8701417 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]